Nuance Pharma

Shanghai, China · Founded 2014 · Privately Held (backing)

Operator of a biopharma platform intended to address critical unmet needs in the Asia Pacific region. Nuance Pharma is based in Shanghai, China and was founded in 2014. Its last reported valuation was $623 million in Jul 2025. It has raised $306 million.

Last reported valuation
$623.1M
Oct 2026
Priced at
—
Total raised
$305.8M
Last round
—

Who backs Nuance Pharma?

9 investors
InvestorType
Shun Xi FundPE / buyout
RTW InvestmentsHedge fund
HBM PartnersVenture capital
Chang DevelopmentOther
Beijing Konruns Pharmaceutical Company—
CBC Group (Singapore)—
GT Fund—
HBM Healthcare Investments—
MPC (Beijing)—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Nuance Pharma investors

9 investors are on record for Nuance Pharma, including Shun Xi Fund, RTW Investments, HBM Partners and Chang Development.

Free account
More of Nuance Pharma with a free account
  • ·Watch Nuance Pharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like Nuance Pharma. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View